Claims for Patent: 11,559,637
✉ Email this page to a colleague
Summary for Patent: 11,559,637
| Title: | Inhalers and related methods |
| Abstract: | An inhaler (10) has a main body for accommodating a medicament reservoir (84), a canister fire system for moving a canister (50) to release a dose in response to air flow, a cap housing (12) for enclosing the canister fire system and canister within an interior chamber defined by the main body (14) and a cap housing, wherein a lock system (250) is provided for locking the cap housing on the main body. |
| Inventor(s): | Daniel Buck, Paul Prendergast, Declan Walsh |
| Assignee: | Norton Waterford Ltd |
| Application Number: | US15/881,358 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 11,559,637 |
| Patent Claims: |
1. A breath actuated inhaler comprising: a main body for accommodating a medicament reservoir, a canister fire system including a trigger; and a biasing element for moving a canister to release a dose in response to air flow, a cap housing, an interior chamber defined by the main body and the cap housing, the canister fire system and canister being enclosed within the interior chamber, and a lock system including helical threads having non-overlapping and distinct thread segments for providing rotational attachment of the cap housing to the main body and a first lock member that cooperates with a second lock member to achieve a snap lock between the cap housing and the main body when the cap housing is rotationally attached to the main body in a locked position, wherein the thread segments are radially disposed about a central axis and arranged such that the thread segments are non-overlapping with respect to each other along the central axis, and wherein the first lock member is interposed between the thread segments. 2. The breath actuated inhaler of claim 1 wherein, in the locked position, the helical threads provide resistance of longitudinal movement between the cap housing and the main body without rotation. 3. The breath actuated inhaler of claim 1 wherein each of the cap housing and the main body include the thread segments and the lock system includes a protrusion extending from a thread segment on one of the main body and the cap housing which is lockable in a recess of a thread segment on the other of the main body and the cap housing. 4. The breath actuated inhaler of claim 3 wherein the lock system includes a second protrusion extending from a thread segment on one of the main body and the cap housing, the second protrusion being lockable in a second recess of a thread segment on the other of the main body and the cap housing, wherein the recess and the second recess are formed at opposing locations on the inhaler. 5. The breath actuated inhaler of claim 3 wherein a thread segment on one of the cap housing and the main body includes a helical groove, and the protrusion extends from the helical groove. 6. The breath actuated inhaler of claim 3 wherein the thread segment on one of the cap housing and the main body includes a radially extending helical protrusion, and the recess is on the radially extending helical protrusion. 7. The breath actuated inhaler of claim 1 wherein the first lock member engages the second lock member along a single face at a lock interface formed by respective engagement faces thereof, the lock interface being oriented substantially perpendicular to tangential. 8. The breath actuated inhaler of claim 7 wherein the first lock member has a radial extent of 0.25 to 0.75 mm and a longitudinal extent of about 10 mm. 9. The breath actuated inhaler of claim 1 in which the main body and the cap housing are formed of plastics material and the lock system is configured so that a release torque required to overcome the lock system is more than 1 Nm. 10. The breath actuated inhaler of claim 9 in which the lock system is configured such that the release torque is between 2 and 5 Nm. 11. A method of treating a respiratory disease or disorder comprising actuating the inhaler of claim 1 to administer a therapeutically effective amount of one or more active ingredients. 12. The method of claim 11, wherein the inhaler is a breath-actuated inhaler and the step of actuating the inhaler comprises inhaling through the inhaler. 13. The method of claim 11, wherein the respiratory disease or disorder is asthma. 14. The method of claim 11, wherein the respiratory disease or disorder is COPD. 15. The method of claim 11, wherein the one or more active ingredients comprise a corticosteroid. 16. The method of claim 11, wherein the one or more active ingredients comprise beclomethasone dipropionate or tiotropium bromide. 17. The breath actuated inhaler of claim 1, wherein the interior chamber comprises a vacuum chamber. 18. The breath actuated inhaler of claim 1, wherein the interior chamber prevents tampering with components within the interior chamber. 19. The breath actuated inhaler of claim 1, wherein the lock system is integrated with the cap housing and main body to resist axial and radial movement of the cap housing relative to the main body. 20. The breath actuated inhaler of claim 1, wherein the cap housing cooperates with the main body to resist axial and radial movement of the cap housing relative to the main body when the lock system is in a locked configuration. 21. The breath actuated inhaler of claim 1, wherein the thread segments are disposed on the cap housing. 22. The breath actuated inhaler of claim 1, wherein the first lock member is disposed on the cap housing and the second lock member is disposed on the main body. 23. The breath actuated inhaler of claim 1, wherein each thread segment has a radial extent that is greater than a radial extent of the first lock member. 24. The breath actuated inhaler of claim 1, wherein the second lock member defines a boundary of a longitudinal cut that is configured and dimensioned to receive the first lock member. 25. The breath actuated inhaler of claim 1, wherein a radial extent of the first lock member is disposed in a same plane as a radial extent of the thread segments. 26. The breath actuated inhaler of claim 1, wherein the first lock member includes a ramp that is inclined relative to a tangent of a radial surface disposed about a central axis. 27. The breath actuated inhaler of claim 26, wherein the ramp includes a terminal end configured to engage the second lock member thereby restricting rotation of the cap housing relative to the main body. 28. A breath actuated inhaler comprising: a main body for accommodating a medicament reservoir, a canister fire system for moving a canister to release a dose in response to air flow, a cap housing for enclosing the canister fire system and canister within an interior chamber defined by the main body and the cap housing, and in which the main body and the cap housing are formed of plastics material characterized in that a lock system is provided for locking the cap housing on the main body, wherein the lock system includes: helical threads having non-overlapping and distinct thread segments for providing rotational attachment of the cap housing on the main body; and a first lock member that cooperates with a second lock member to achieve a snap lock between the cap housing and the main body when the cap housing is rotationally attached to the main body in a locked position, wherein the thread segments are radially disposed about a central axis and arranged such that the thread segments are non-overlapping with respect to each other along the central axis, wherein the first lock member is interposed between the thread segments, and wherein a release torque required to overcome the lock system is more than 1 Nm and lower than 4 Nm. 29. The breath actuated inhaler of claim 28 wherein, in the locked position, the helical threads provide resistance of longitudinal movement between the cap housing and the main body without rotation. 30. The breath actuated inhaler of claim 28 wherein each of the cap housing and the main body include the thread segments and the lock system includes a protrusion extending from a thread segment on one of the main body and the cap housing which is lockable in a recess of a thread segment on the other of the main body and the cap housing. 31. The breath actuated inhaler of claim 30 wherein the lock system includes a second protrusion extending from a thread segment on one of the main body and the cap housing, the second protrusion being lockable in a second recess of a thread segment on the other of the main body and the cap housing, wherein the recess and the second recess are formed at opposing locations on the inhaler. 32. The breath actuated inhaler of claim 28 wherein the first lock member engages the second lock member along a single face at a lock interface formed by respective engagement faces thereof, the lock interface being oriented substantially perpendicular to tangential. 33. The breath actuated inhaler of claim 32 wherein the first lock member has a radial extent of 0.25 to 0.75 mm and a longitudinal extent of about 10 mm. 34. A method of treating a respiratory disease or disorder comprising actuating the inhaler of claim 28 to administer a therapeutically effective amount of one or more active ingredients. 35. The method of claim 34, wherein the inhaler is a breath-actuated inhaler and the step of actuating the inhaler comprises inhaling through the inhaler. 36. The method of claim 34, wherein the respiratory disease or disorder is asthma. 37. The method of claim 34, wherein the respiratory disease or disorder is COPD. 38. The method of claim 34, wherein the one or more active ingredients comprise a corticosteroid. 39. The method of claim 34, wherein the one or more active ingredients comprise beclomethasone dipropionate or tiotropium bromide. 40. The breath actuated inhaler of claim 28, wherein the interior chamber comprises a vacuum chamber. 41. The breath actuated inhaler of claim 28, wherein the interior chamber prevents tampering with components within the interior chamber. 42. The breath actuated inhaler of claim 28, wherein the lock system is integrated with the cap housing and main body to resist axial and radial movement of the cap housing relative to the main body. 43. The breath actuated inhaler of claim 28, wherein the cap housing cooperates with the main body to resist axial and radial movement of the cap housing relative to the main body when the lock system is in a locked configuration. 44. The breath actuated inhaler of claim 28, wherein the thread segments are disposed on the cap housing. 45. The breath actuated inhaler of claim 28, wherein the first lock member is disposed on the cap housing and the second lock member is disposed on the main body. 46. The breath actuated inhaler of claim 28, wherein each thread segment has a radial extent that is greater than a radial extent of the first lock member. 47. The breath actuated inhaler of claim 28, wherein the second lock member defines a boundary of a longitudinal cut that is configured and dimensioned to receive the first lock member. 48. The breath actuated inhaler of claim 28, wherein a radial extent of the first lock member is disposed in a same plane as a radial extent of the thread segments. 49. The breath actuated inhaler of claim 28, wherein the first lock member includes a ramp that is inclined relative to a tangent of a radial surface disposed about a central axis. 50. The breath actuated inhaler of claim 49, wherein the ramp includes a terminal end configured to engage the second lock member thereby restricting rotation of the cap housing relative to the main body. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
